問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Taichung Veterans General Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
Division of Endocrinology
下載
2005-06-01 - 2006-12-01
Condition/Disease
Test Drug
Participate Sites7Sites
Terminated7Sites
2006-01-26 - 2011-01-26
2022-06-30 - 2024-10-15
xxxxxx
Participate Sites4Sites
Terminated4Sites
2023-02-01 - 2025-12-31
Severe Hypertriglyceridemia
Olezarsen (ISIS 678354)
Recruiting7Sites
2024-08-01 - 2027-12-31
Participate Sites6Sites
Recruiting6Sites
2009-01-01 - 2010-06-30
Participate Sites3Sites
Terminated3Sites
2007-02-01 - 2008-04-30
Participate Sites5Sites
Terminated5Sites
2016-08-01 - 2019-07-31
Participate Sites1Sites
Terminated1Sites
2023-03-01 - 2027-04-30
Atherosclerotic Cardiovascular Disease
olpasiran (AMG 890)
Participate Sites10Sites
Recruiting9Sites
Division of General Internal Medicine
2019-05-02 - 2026-01-17
Recruiting10Sites
全部